Comprehensive CSF proteomics reveals that brain endothelial proteins are prominently and coordinately altered in the earliest preclinical stages of AD. Endothelial biomarkers act as key drivers of functional protein networks associated with amyloid, tau, synaptic dysfunction, and cognition.